CoChat

Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms

Open access
Uppuluri, Priya, Nett, Jeniel, Heitman, Joseph, Andes, David · 2008 · Antimicrobial Agents and Chemotherapy

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Calcineurin is a Ca 2+ -calmodulin-activated serine/threonine-specific protein phosphatase that governs multiple aspects of fungal physiology, including cation homeostasis, morphogenesis, antifungal drug susceptibility, and virulence. Growth of Candida albicans planktonic cells is sensitive to the calcineurin inhibitors FK506 and cyclosporine A (CsA) in combination with the azole antifungal fluconazole. This drug synergism is attributable to two effects: first, calcineurin inhibitors render fluconazole fungicidal rather than simply fungistatic, and second, membrane perturbation by azole inhibition of ergosterol biosynthesis increases intracellular calcineurin inhibitor concentrations. C. albicans cells in biofilms are up to 1,000-fold more resistant to fluconazole than planktonic cells. In both in vitro experiments and in an in vivo rat catheter model, C. albicans cells in biofilms were resistant to individually delivered fluconazole or calcineurin inhibitors but exquisitely sensitive to the combination of FK506-fluconazole or CsA-fluconazole. C. albicans strains lacking FKBP12 or expressing a dominant FK506-resistant calcineurin mutant subunit (Cnb1-1) formed biofilms that were resistant to FK506-fluconazole but susceptible to CsA-fluconazole, demonstrating that drug synergism is mediated via direct calcineurin inhibition. These findings reveal that calcineurin contributes to fluconazole resistance of biofilms and provide evidence that synergistic drug combinations may prove efficacious as novel therapeutic interventions to treat or prevent biofilms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.01397-07

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 228

Metadata

Authors
Uppuluri, P., Nett, J., Heitman, J., & Andes, D.
Affiliations
  • Duke Medical Center (US)
  • University of Wisconsin–Madison (US)
Corresponding author
  • Heitman, Joseph
  • Andes, David
Venue
Antimicrobial Agents and Chemotherapy
Published
2008-03
Volume
52
Issue
3
Pages
1127-1132
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2127992552
Cited by
228
References
40
Citations by year
2026: 9 · 2025: 11 · 2024: 5 · 2023: 10 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 13 · 2018: 9 · 2017: 14 · 2016: 14 · 2015: 19 · 2014: 16 · 2013: 17 · 2012: 18
FWCI
7.71
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (NIH-R01)
  • Department of Biology, Duke University
  • National Heart, Lung, and Blood Institute (T32HL007899)
  • National Institute of Allergy and Infectious Diseases (R01AI042159, R01AI42159, R01 AI50438, R01AI050438)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
Candida albicans, biofilm, calcineurin, calcineurin inhibitors, FK506, cyclosporine, fluconazole, drug synergy, antifungal resistance, azole antifungals, ergosterol biosynthesis, membrane perturbation, FKBP12, catheter-related infection, combination therapy
MeSH terms
Animals, Antifungal Agents, Candida albicans, Drug Synergism, Humans, Microbial Sensitivity Tests, Fluconazole, Tacrolimus, Cyclosporine, Biofilms, Drug Resistance, Fungal, Rats, Calcineurin Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.